에 대한 최신 뉴스 Agilon Health (NYSE:AGL) 주식

AGILON HEALTH INC

Agilon Health

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

AerovironmentRichmond,,Virginia,,Usa,-,8,May,2019:,Illustrative,Editorial,Of

Equities

Mid Cap

News

Movers

Trading Ideas

AVAV

CERT

LOAR

ORLA

RXRX

RYTM

SBSW

STRL

리커전·아이엠골드 등 지난주 시장 변동성 속 급등한 중형주 11종목 (4월 7일~11일) 지난주 최고의 성과를 올린 중형주는 다음과 같다.

리커전·아이엠골드 등 지난주 시장 변동성 속 급등한 중형주 11종목 (4월 7일~11일)

Agilon Health Inc

T2 Metals Corp

Adventure Gold - United States Dollar

AUSTRAL GOLD LTD ORD by Austral Gold Ltd.

Austral Gold Ltd

ANGELALIGN TECH INC by Angelalign Technologies Inc.

Angelalign Technology Inc

AGL Energy Ltd

AGILITY CAPITAL HOLDING by AGILITY CAPITAL HOLDING INC.

Agility Capital Holding Inc

ANGEL TELECOM CORP by Angel Telecom Corp.

AgileThought Inc

ATLANTIS GLORY INC by Atlantis Glory Inc.

Atlantis Glory Inc

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Thursday.
Shares of H.B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) rose sharply in Thursday's session after the company reported better-than-expected second-quarter earnings and raised its FY2025 adjusted EPS <a href="https://www.benzinga.com/quote/FUL/earnings">guidance above estimates</a>.
H.B. Fuller reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $1.08 per share. The company reported quarterly sales of $898.095 million which missed the analyst consensus estimate of $899.955 million.
H.B. Fuller shares jumped 10.8% to $61.60 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>BlackSky Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NASDAQ">BKSY</a>) shares jumped 16.5% to $20.12. Canaccord Genuity analyst Austin Moeller maintained BlackSky Technology with a Buy and raised the price target from $14 to $20.</li>
<li>TSS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) gained 16.5% to $31.68.</li>
<li>Worthington Steel, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) gained 14.5% to $30.06 as the company reported stronger-than-expected financial results for the fourth quarter.</li>
<li>Rocket Lab Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) climbed 13.5% to $36.72.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) gained 13.1% to $15.15.</li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) rose 12.5% to $35.80.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 12.2% to $5.40.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) surged 11% to $220.66.</li>
<li>VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) gained 10.7% to $45.17.</li>
<li>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) shares rose 10.6% to $42.18.</li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) jumped 10% to $21.08.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) gained 10% to $5.96.</li>
<li>AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) rose 9.8% to $258.01. AeroVironment recently reported better-than-expected quarterly financial results.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) gained 9% to $24.48.</li>
<li>MillerKnoll, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) rose 6% to $18.64 after the company reported better-than-expected quarterly EPS and sales.</li>
<li>Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) gained 5.5% to $29.73.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

BBAI

BlackSky Technology Inc. Class A Common Stock

BKSY

CRCL

ENPH

FWRD

LZMH

MLKN

NNNN

OSCR

RKLB

TSSI

VEON

H.B. Fuller Posts Better-Than-Expected Earnings, Joins AeroVironment, MillerKnoll And Other Big Stocks Moving Higher On Thursday

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) is once again capturing attention as technical signals and fundamental developments point toward a potential bullish breakout. 
With rising institutional involvement and the latest upgrades to the XRP Ledger, traders are closely watching for confirmation of <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">a trend shift.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
<td>Market Cap</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.16</td>
<td>$2.6 billion</td>
<td>+0.4%</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$107,265.47</td>
<td>&nbsp;$2.13 trillion</td>
<td>+2.3%&nbsp;</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,450.40</td>
<td>&nbsp;$295.9 billion</td>
<td>-3%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto analyst Cryptoinsightuk highlighted strong bullish signals on XRP's weekly chart.
If XRP closes the week at or above current levels, it will mark the first bullish engulfing candle at a higher low since its local top in January, often a precursor to a major move.
Both the RSI and Stochastic RSI are close to forming a bullish cross, indicating strengthening momentum. 
A breakout above the descending trendline, around 8% above current price, would confirm the move and set the stage for an aggressive rally.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> weekly showing promising signs. If we close here or above for <a href="https://twitter.com/search?q=%24XRP&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$XRP</a> on the weekly, it will be the first time we&#39;ve seen a Bullish Engulfing candle on a higher low since our local top back in January. This could suggest that we are finishing our recent consolidation /… <a href="https://t.co/gn0eYvyI2O">pic.twitter.com/gn0eYvyI2O</a>
&mdash; Cryptoinsightuk (@Cryptoinsightuk) <a href="https://twitter.com/Cryptoinsightuk/status/1938156880221667798?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Rose Premium Signals <a href="https://x.com/VipRoseTr/status/1938180642681811450">echoed</a> this outlook, noting that XRP is pressing against a long-standing descending trendline following a solid bounce from support. 
A breakout would likely trigger a continuation rally, with key price targets at $2.4558 and $2.6549. 
Traders are eyeing a retest entry as an ideal setup.
Community News: Ripple recently <a href="https://ripple.com/insights/unlocking-institutional-access-to-defi-on-the-xrp-ledger/">announced </a>the rollout of a Permissioned DEX on the XRP Ledger, tailored for institutional players seeking DeFi access while maintaining compliance. 
This system allows regulated financial institutions to trade on decentralized infrastructure—using permissioned order books for assets like XRP, stablecoins, and wrapped tokens.
In a major boost to XRP's credibility, the European Central Bank <a href="https://www.ainvest.com/news/xrp-news-today-ecb-selects-xrp-ledger-digital-euro-pilot-program-starting-june-2025-2506/">selected</a> the XRP Ledger for its 12-month Digital Euro pilot beginning in June 2025. 
This highlights XRPL's growing role in digital asset tokenization and real-world settlement solutions across Europe. 
Ripple's infrastructure is set to be a foundational layer in the ECB's exploration of central bank digital currencies (CBDCs).
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46054595/xrp-sheds-10-in-seven-days-so-why-are-traders-still-bullish">XRP Sheds 10% In Seven Days – So Why Are Traders Still Bullish?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Stuck Below $2.20: Why Is It Not Moving?

JMP Securities analyst Aaron Hecht upgrades PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) from Market Perform to Market Outperform and announces $24 price target.

Upgrades

Price Target

Analyst Ratings

PENN

JMP Securities Upgrades PENN Entertainment to Market Outperform, Announces $24 Price Target

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) with a Buy and lowers the price target from $24 to $23.

TEVA

UBS Maintains Buy on Teva Pharmaceutical Indus, Lowers Price Target to $23

UBS analyst Timothy Arcuri maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Buy and raises the price target from $120 to $155.

UBS Maintains Buy on Micron Technology, Raises Price Target to $155

Global

BYDDF

XIACF

XIACY

XPEV

Reuters Reports Xiaomi Gets Over 200,000 Pre-Orders Of YU7 SUV In 3-Minutes

UBS analyst Peyton Dorne maintains Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) with a Buy and raises the price target from $215 to $255.

GPOR

UBS Maintains Buy on Gulfport Energy, Raises Price Target to $255

JLHL

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

JMP Securities analyst Jordan Bender downgrades MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>) from Market Outperform to Market Perform.

Downgrades

JMP Securities Downgrades MGM Resorts International to Market Perform

WIIM

PRSO

PRSO stock has given up its prior gain. Peraso shares were trading higher after the company announced an unsolicited non-binding proposal to acquire Peraso in an all-stock deal.

Morgan Stanley analyst Vincent Andrews maintains CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) with a Equal-Weight and raises the price target from $80 to $95.

Morgan Stanley Maintains Equal-Weight on CF Industries Holdings, Raises Price Target to $95

<a href="https://www.globenewswire.com/Tracker?data=oXeEq9J56C70uDyHmrKrFfL2Tmo6pMSGMRLBwqpdKLMjXBSyB-jMxljZ9Fri-RUm5BtwZR-HLedZnsEenONOgtQY1Hf_af0Tiw5MMT-JZHs=">Genius Group Limited</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNS#NYSE">GNS</a>) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that its Board of Directors have approved a distribution plan from the proceeds of any and all future legal wins, with net proceeds divided equally for distribution to shareholders and purchase of Bitcoin for its Bitcoin Treasury.
Genius Group's CEO, Roger Hamilton said "The Company has two legal cases, one filed and one pending, in which we are seeking combined damages of over $1 billion. As both lawsuits are being pursued by the Company to recover damages caused by third parties directly to our shareholders, the Board believes that 100% of any proceeds from the successful outcome of these cases should be directly distributed or reinvested for the benefit of shareholders."
The Company currently has filed a complaint under the Racketeer Influenced and Corrupt Organizations Act (RICO), in the United States District Court, Southern District of Florida against Peter Ritz and Michael Moe as the controlling officers and directors of LZGI International, Inc ("LZG") and against Michael Carter and John Clayton, seeking damages of over $750 million (which includes treble damages potentially recoverable under federal statute) caused by the defendants to Genius Group. (Case No: 1:25-cv-21496)
The Company also has an upcoming lawsuit alleging naked short selling and evidence of spoofing against certain parties, led by Wes Christian of Christian Attar, with alleged damages calculated at between $251.3 million and $262.7 million following the initial analysis of the Company's share trading data in 2023. The Company's legal team has continued detailed tracking of all trades in the Company for 2024 and 2025, and the filing, which is currently in final review pending filing, will include an updated damages amount which the Company anticipates to be significantly higher than the 2023 calculation based on the information provided.
Whilst there is no guarantee on the final outcome of either case, the time frames of the cases or on the amount of damages that the Company may win or recover, in the event that the Company is successful in recovering any damages, the Board has agreed to the following distribution:
<ul>
<li>Distribution of 50% of any net damages recovered by way of special dividend to shareholders, to be issued once any net damages have been recovered. &nbsp;</li>
<li>Investment of 50% of any net damages recovered in purchasing Bitcoin for the Company's Bitcoin Treasury, to be purchased once any net damages have been recovered. &nbsp;</li>
</ul>
In the event there are multiple instances of damage recovery, the distribution will apply to each instance. Net damages will be damages received by the Company net of legal fees, recovery fees and tax. Any and all distributions will be subject to applicable rules by the relevant regulatory bodies including the SEC, NYSE and Singapore law.

Dividends

Genius Group Board Approves 50/50 Split Of Future Legal Win Proceeds, Half As Shareholder Dividend, Half For Bitcoin Treasury Purchases; Potential Claims Exceed $1B

Morgan Stanley analyst Vincent Sinisi maintains Nutrien (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTR#NYSE">NTR</a>) with a Equal-Weight and raises the price target from $60 to $65.

Morgan Stanley Maintains Equal-Weight on Nutrien, Raises Price Target to $65

JMP Securities analyst Greg Miller reiterates Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) with a Market Outperform and maintains $1200 price target.

Reiteration

EQIX

JMP Securities Reiterates Market Outperform on Equinix, Maintains $1200 Price Target

McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) has outperformed the market over the past 15 years by 4.58% on an annualized basis producing an average annual return of 17.22%. Currently, McKesson has a market capitalization of $90.92 billion. 
Buying $100 In MCK: If an investor had bought $100 of MCK stock 15 years ago, it would be worth $1,086.27 today based on a price of $727.91 for MCK at the time of writing.
<h3>McKesson's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750946680_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

UBS analyst Peter Grom maintains General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Sell and lowers the price target from $52 to $49.

UBS Maintains Sell on General Mills, Lowers Price Target to $49

Morgan Stanley analyst Joseph Moore maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Equal-Weight and raises the price target from $98 to $135.

Morgan Stanley Maintains Equal-Weight on Micron Technology, Raises Price Target to $135

JMP Securities analyst Jonathan Wolleben reiterates DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) with a Market Outperform and maintains $21 price target.

DBVT

JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $21 Price Target

<a href="https://www.benzinga.com/25/05/45535042/recession-odds-tumble-on-kalshi-crypto-based-polymarket-as-trumps-tariff-concerns-subside">Prediction market platform Kalshi</a> has secured a $185 million Series C funding round, pushing the company's valuation to $2 billion.
The round was led by Paradigm and Sequoia, with participation from both new and existing investors.
"Kalshi today is one of the fastest growing companies in America," co-founder and CEO Tarek Mansour <a href="https://www.cnbc.com/video/2025/06/26/kalshi-ceo-on-hitting-2b-valuation-were-one-of-the-fastest-growing-companies-in-america.html">told</a> CNBC in an interview. 
According to Mansour, the platform has seen rapid growth across all major metrics. 
"We 50x'd our user base last year. This year, the user base is growing around 100x, and the number of markets has scaled 15x just from last October," he said.
Kalshi's growth is not only reflected in user numbers but also in financial performance. 
"Our revenue has scaled meaningfully and the company is doing very well on the financial side," Mansour said.
The fresh funding will be used to expand Kalshi's talent pool, scale market offerings, and meet rising demand from brokerages seeking to integrate Kalshi's prediction markets. 
"We've built an incredible talent density in New York," Mansour said, adding that Kalshi is recruiting engineers, traders, economists, and product designers, with many hires coming from both Silicon Valley and Wall Street.
"We cannot compete with the salaries that some hedge funds are paying," Mansour noted, but said equity remains a key part of Kalshi's compensation strategy. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46112072/coinbase-is-the-amazon-of-crypto-services-price-target-boosted-to-510-bernstein">Coinbase Is The &#8216;Amazon Of Crypto Services&#8217;, Price Target Boosted To $510: Bernstein</a>
"People don't join Kalshi for the fancy investors or the money. They join for the mission, what we're building."
Kalshi has also expanded its market offerings, growing from around 100 markets in October to approximately 1,500 today, with plans to double or triple that number by year's end. 
Key growth areas include sports and political prediction markets.
Mansour pointed out that Kalshi's markets had provided real-time pricing that, in some cases, outpaced traditional Wall Street expectations. 
Reflecting on the recent New York City mayoral race, Mansour said, "Our markets were not really caught off guard. Our markets were pricing it."
Kalshi's data also showed interesting demographic splits in trading patterns during the election. 
According to Mansour, women predominantly backed Mamdani, while the support among men was evenly split. 
Younger participants leaned toward Mamdani, while older ones favored Cuomo.
In political prediction markets, Kalshi is already seeing volume around the Democratic primaries.
 Alexandria Ocasio-Cortez and Gavin Newsom are currently leading the odds, according to Mansour. 
&#8220;AOC is around 14%, Newsom is at around 13%, and Buttigieg is below 10%.&#8221;
Asked about confidence in these long-range predictions, Mansour responded, "There's a lot that can happen in three and a half years, but it's a gauge. This is where we're at today and this is what the market thinks."
Mansour also noted a sharp increase in odds for New York Mayor Eric Adams in recent days. 
&#8220;Eric Adams has shot up 400% in the last 36 hours… I always say 24% is 24%. It's not zero. He could pull it off."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46114220/asias-microstrategy-metaplanet-acquires-additional-1234-bitcoin-as-etfs-extend-12-day-inflow-streak">&#8216;Asia&#8217;s MicroStrategy&#8217; Metaplanet Acquires Additional 1,234 Bitcoin As ETFs Extend 12-Day Inflow Streak</a></li>
</ul>
Image: Shutterstock

Education

Prediction Market Kalshi Raises $185M, Surges To $2B Valuation

<a href="https://www.richmondfed.org/press_room/media_advisories/2025/20250623_barkin_ny#:~:text=Richmond%20Fed%20President%20Tom%20Barkin,%2C%202025%2C%20in%20New%20York.&amp;text=Speech%20is%20scheduled%20for%208,event%20also%20includes%20audience%20Q%26A" title="https://www.richmondfed.org/press_room/media_advisories/2025/20250623_barkin_ny#:~:text=Richmond%20Fed%20President%20Tom%20Barkin,%2C%202025%2C%20in%20New%20York.&amp;text=Speech%20is%20scheduled%20for%208,event%20also%20includes%20audience%20Q%26A">https://www.richmondfed.org/press_room/media_advisories/2025/20250623_barkin_ny#:~:text=Richmond%20Fed%20President%20Tom%20Barkin,%2C%202025%2C%20in%20New%20York.&amp;text=Speech%20is%20scheduled%20for%208,event%20also%20includes%20audience%20Q%26A</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Barkin Says Won't Take Any Action Off The Table But Does Seek More Data; Says Important To Defend Integrity Of Economic Data

Press Releases

agilon health Sets Date to Report Fourth Quarter and Full Year 2024 Financial Results

Legal

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of agilon health, inc. (NYSE: AGL) and Encourages Long-Term Investors to Contact the Firm

agilon health to Participate in TD Cowen's 45th Annual Health Care Conference

agilon health Reports Fourth Quarter and Full Year Fiscal 2024 Results

agilon health Sets Date to Report First Quarter 2025 Financial Results

agilon health to Participate in BofA Securities 2025 Health Care Conference

agilon health Reports First Quarter 2025 Results

agilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference

New Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare Patients

New Study Finds Senior Patients Managed by Women Physicians in a Value-Based Care (VBC) Model Have Equal or Better Clinical and Quality Outcomes and Less Healthcare Utilization

Addus HomeCare Corporation - Common Stock

Addus HomeCare

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

DocGo

Enhabit

Fulgent Genetics

InnovAge Holding

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

National Research Corporation - Common Stock

National Research

Nutex Health

Omada Health

OPKO Health

Performant Healthcare, Inc. - Common Stock

Performant Healthcare

Premier

Pennant Gr

Privia Health Gr

Talkspace

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Holdings

Wells Fargo

Barclays

Goldman Sachs

Citigroup

TD Cowen

지난주 최고의 성과를 올린 중형주는 다음과 같다.
<ol>
<li>애질론 헬스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) 주가는 36.87% 급등했다. 번스타인 애널리스트 아미르 파라한이 시장수익률에서 시장수익률 상회로 투자의견을 상향하고 <a href="https://www.benzinga.com/quote/agl/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 3.3달러에서 8.5달러로 상향 조정</a>했다.</li>
<li>리커전 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) 주가는 미국 식품의약국의 동물 실험에 대한 뉴스로 35.85% 상승했다.</li>
<li>서타라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) 주가는 35.18% 상승했다. 미국 식품의약국은 단클론 항체 치료제 및 기타 약물 평가에서 큰 변화를 발표하며 <a href="https://www.benzinga.com//node/44764201" target="_blank" rel="noreferrer noopener">전통적인 동물 실험에서의 전환</a>을 강조했다.</li>
<li>에어로바이런먼트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) 주가는 31.06% 상승했다. 아마도 트럼프 대통령이 <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty" target="_blank" rel="noreferrer noopener">중국을 제외한 모든 국가에 대한 90일 간의 보복 관세 중단 결정을 내린 것</a>과 관련이 있을 것이다.</li>
<li>스털링 인프라스트럭처(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NYSE">STRL</a>) 주가는 30.61% 상승했다. 아마도 트럼프 대통령이 <a href="https://www.benzinga.com/25/04/44720006/markets-take-off-as-trump-announces-90-day-tariff-pause-for-non-retaliating-nations-slaps-china-with-125-duty" target="_blank" rel="noreferrer noopener">중국을 제외한 모든 국가에 대한 90일 간의 보복 관세 중단 결정을 내린 것</a>과 관련이 있을 것이다.</li>
<li>올라 마이닝(AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ORLA#AMEX">ORLA</a>) 주가는 29.35% 상승했다.</li>
<li>아이엠골드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) 주가는 28.24% 상승했으며, 아마도 금과 은이 거시적 불확실성 속에서 상승했기 때문이다.</li>
<li>시바니 스틸워터(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSW#NYSE">SBSW</a>) 주가는 지난 주 금과 은이 거시적 불확실성 속에서 상승하면서 27.33% 상승했다.</li>
<li>로어 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOAR#NYSE">LOAR</a>) 주가는 27.20% 상승했다.</li>
<li>리듬 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) 주가는 회사가 <a href="https://www.benzinga.com//node/44670213" target="_blank" rel="noreferrer noopener">3상 TRANSCEND 시험이 주요 목표를 충족했다</a>고 발표한 이후 26.84% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/rytm/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표를 상향 조정했다</a>.</li>
<li>텔릭스 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLX#NASDAQ">TLX</a>) 주가는 22.34% 급등했다. 회사는 <a href="https://www.benzinga.com//node/44680639" target="_blank" rel="noreferrer noopener">전립선암을 위한 PSMA-PET 이미징 제제 고젤릭스(Gozellix)의 유통을 카디널 헬스에 맡겼다</a>.</li>
</ol>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Agilon Health

뉴스

에 대한 최신 뉴스 Agilon Health (NYSE:AGL) 주식

일요일, 4월 13, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌